The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
ConclusionsThe NETest exhibits clinically competent metrics as an effective biomarker for neuroendocrine tumors. Measurement of NET transcripts in blood is a significant advance in neuroendocrine tumor management and demonstrates that blood provides a viable source to identify and monitor tumor status.
Source: Advances in Medical Sciences - Category: Biomedical Science Source Type: research
More News: Biology | Biomedical Science | Brain | Cancer & Oncology | Gastroenterology | Laboratory Medicine | Neurology | Paraganglioma | Pheochromocytoma